Telemonitoring of Chronic Wound Patients Using MyDerm, a Digital Solution: Feasibility Study (PIXAPROM)

December 5, 2025 updated by: Pixacare

Télésurveillance de Patients Porteurs d'Une Plaie Chronique à l'Aide d'Une Solution numérique MyDerm : étude de faisabilité

The aim of this study is to assess the feasibility of integrating myDerm for remote monitoring of chronic wounds into everyday practice, for patients over 18 years of age suffering from a single chronic wound of the lower limb (more than 6 weeks old).

Outcome measure 1 :

Evaluate patient satisfaction after 2 months of using the MyDerm solution.

Outcome measure 2 :

  1. Evaluate caregiver satisfaction after 2 months of patient use of MyDerm solution.
  2. Assess patient use (compliance, frequency) of MyDerm solution
  3. Evaluate caregiver use of PIXACARE solution
  4. Evaluate the impact of patients' socio-demographic characteristics (age, gender, level of education: primary/secondary/tertiary, rural/urban) on use of the MyDerm solution.
  5. Evaluate the impact of patients' clinical characteristics on the use of the MyDerm solution.

Researchers will compare standard of care arm vs remote monitoring arm.

As part of remote monitoring, patients are invited to take photos of their wounds using their smartphone, and to answer a simple questionnaire to look for signs of complications. To assess satisfaction, the patient will complete a questionnaire after 2 months' use, using a 7-level Likert scale.

Study Overview

Status

Completed

Detailed Description

Observational, monocentric study of patients with chronic wounds of the lower limb benefiting from the digital solution for remote monitoring of wound healing.

Clinical data will be collected by the investigating team during the primary consultation.

Patient satisfaction surveys will be sent in paper format to patients at the consultation scheduled at the end of the two-month follow-up period.

Caregiver" satisfaction surveys will be sent in paper format to caregivers at the end of the study.

The number of actions taken in response to an alert (by telephone, by message, organization of a physical consultation, organization of a teleconsultation, hospitalization) will be recorded in the post-alert action traceability form

Study Type

Observational

Enrollment (Actual)

25

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • France
      • Corbeil-Essonnes, France, France, 91106
        • Centre Hospitalier Sud Francilien

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients with chronic wounds of the lower limb benefiting from the digital solution for remote monitoring of healing at hospital

Description

Inclusion Criteria:

  • Patient with a single chronic wound of the lower limb (more than 6 weeks)
  • Benefiting from the MyDerm digital wound-healing monitoring solution
  • Patient aged 18 or over
  • Informed patient who has not objected to the use of data

Exclusion Criteria:

  • Patient refusing to participate in the study
  • Patient included in a clinical trial
  • Patient with a life expectancy shorter than the duration of the study
  • Patient with cognitive impairment
  • Inability to install or use the medical device for technical reasons (lack of internet connection, lack of 4G coverage or more, lack of smartphone)
  • Patient requiring home hospital care
  • Patient requiring Follow-up and rehabilitation care
  • Pregnant or breast-feeding women
  • Patient with a previously infected wound

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Telemonitoring
patients with chronic wounds of the lower limb benefiting from the digital solution for remote monitoring of healing.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Response to questionnaire completed after two months of use
Time Frame: At 2 months
The satisfaction questionnaire using a 7-point Likert scale
At 2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Responses to the caregiver questionnaire completed at the end of the study using a 7-point Likert scale
Time Frame: At 2 months
The satisfaction questionnaire using a 7-point Likert scale
At 2 months
Patient use of the MyDerm solution
Time Frame: At 2 months
A. Number of patients with at least one telefile B. Total number of teledeposits generated per patient during the follow-up period C. Number of teledeposits per week per patient over the entire follow-up period (evolution of usage over the follow-up period)
At 2 months
The impact of patients' socio-demographic characteristics on use of the MyDerm solution
Time Frame: At 2 months
Number of patients with at least one telefile
At 2 months
The impact of patients' socio-demographic characteristics on use of the MyDerm solution
Time Frame: AT 2 months
Total number of teledeposits generated per patient during follow-up period
AT 2 months
The impact of patients' socio-demographic characteristics on use of the MyDerm solution
Time Frame: AT 2 months
Number of teledeposits per week per patient over the entire follow-up period (evolution of usage over the follow-up period)
AT 2 months
Use of PIXACARE solution by caregivers
Time Frame: At 2 months
Number of telemonitoring records opened per patient by the medical team during the follow-up period.
At 2 months
Use of PIXACARE solution by caregivers
Time Frame: AT 2 months
Total number of alerts and number of alerts per patient during follow-up period
AT 2 months
Use of PIXACARE solution by caregivers
Time Frame: At 2 months
Number of actions by telephone related to an alert
At 2 months
Use of PIXACARE solution by caregivers
Time Frame: At 2 months
Number of e-mail related to an alert
At 2 months
Use of PIXACARE solution by caregivers
Time Frame: AT 2 months
Number of organization of a physical consultation related to an alert
AT 2 months
Use of PIXACARE solution by caregivers
Time Frame: At 2 months
Number of organization of a teleconsultation
At 2 months
Use of PIXACARE solution by caregivers
Time Frame: At 2 months
Number of hospitalization related to an alert
At 2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 6, 2025

Primary Completion (Actual)

April 23, 2025

Study Completion (Actual)

October 16, 2025

Study Registration Dates

First Submitted

November 19, 2024

First Submitted That Met QC Criteria

November 21, 2024

First Posted (Actual)

November 25, 2024

Study Record Updates

Last Update Posted (Actual)

December 12, 2025

Last Update Submitted That Met QC Criteria

December 5, 2025

Last Verified

November 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lower Limb Wound

Subscribe